DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, was recognized at the 2nd Annual Biopharma Asia Industry Awards in Singapore.
The awards program was launched to celebrate Asia's evolving importance as a destination for life science partnerships and business activities.
According to the sponsors, the award aims to recognize the best contract manufacturing organization (CMO) that has demonstrated an ongoing commitment to improve its services in Asia and in reducing lead times for its customers.
DSM BioSolutions, the business unit of DSM Pharmaceutical Products recognized, offers CMO development and manufacturing services related to cGMP microbial fermentation with production platforms developed for a variety of micro-organisms ranging from pharmaceutical proteins to metabolites and enzymes.
"DSM is committed to providing solutions for the future of biopharmaceutical manufacturing, and DSM is driving sustainability and 'peace of mind' for both small and large molecule production across our pharma offering,” said Alexander Wessels, CEO of DSM Pharmaceutical Products.
